Finished dosage forms
In one of the
largest and most modern pharmaceutical factories in Europe, the Company manufactures
solid forms of drugs, such as tablets, coated and film-coated tablets, effervescent tablets, and hard capsules. The production capacity for solid forms is 6 billion units per year. Full hermetization allows for the protection of drugs against any possible contaminants, as well as the protection of employees against contact with chemical substances.
/userfiles/images/dla_partnerow_biznesowych/chemia.jpg)
Active pharmaceutical ingredients
The total capacity of the company reactors is 320,000 liters. The facilities for manufacturing
APIs are subject to regular
FDA inspections. Installations for the production of substances and finished dosage forms have
GMP certificates issued by the
General Pharmaceutical Inspectorate and PIC/S (Pharmaceutical Inspection Cooperation Scheme).
Business development
Besides for manufacturing for its own purposes, the Company provides contract production services with regard to the manufacture of APIs, solid forms and liquid forms of drugs. We also offer
registration documentation for finished dosage forms manufactured based on own pharmaceutical APIs, as well as substances acquired from external suppliers. Documentation is prepared in the
CTD format compliant with the EU requirements.
Environmental protection and safety at work
Polpharma implemented the
Integrated Environmental and OSH Management System. As evidence that it meets the international standards in that respect, the company was awarded the
ISO 14001 and OHSAS 18001/PN-N-18001 certificates as
issued by
Det Norske Veritas (DNV).